Sign In
Buy PRNB
$100.05
+0 (+0%)
At Close: May 27, 2022
Axa Increases Stock Holdings in Principia Biopharma Inc (NASDAQ:PRNB)
09:28am, Sunday, 29'th Mar 2020
Axa grew its position in Principia Biopharma Inc (NASDAQ:PRNB) by 6.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The
Algert Global LLC Makes New $410,000 Investment in Principia Biopharma Inc (NASDAQ:PRNB)
08:28am, Friday, 27'th Mar 2020
Algert Global LLC bought a new position in Principia Biopharma Inc (NASDAQ:PRNB) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
Principia Biopharma (NASDAQ:PRNB) Upgraded at BidaskClub
06:52am, Friday, 27'th Mar 2020
Principia Biopharma (NASDAQ:PRNB) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report released on Friday, BidAskClub reports. Several oth
Principia Biopharma Inc (NASDAQ:PRNB) Given Consensus Recommendation of "Buy" by Brokerages
05:22am, Friday, 27'th Mar 2020
Principia Biopharma Inc (NASDAQ:PRNB) has been given a consensus rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated
Principia Biopharma (NASDAQ:PRNB) Trading Up 6%
07:02am, Thursday, 26'th Mar 2020
Principia Biopharma Inc (NASDAQ:PRNB)’s stock price was up 6% on Tuesday . The company traded as high as $52.60 and last traded at $49.82, approximately 401,744 shares changed hands during trading.
Bank of Montreal Can Has $127,000 Position in Principia Biopharma Inc (NASDAQ:PRNB)
10:52am, Wednesday, 25'th Mar 2020
Bank of Montreal Can lifted its stake in shares of Principia Biopharma Inc (NASDAQ:PRNB) by 88.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commissi
1,716,734 Shares in Principia Biopharma Inc (NASDAQ:PRNB) Purchased by BVF Inc. IL
09:48am, Sunday, 22'nd Mar 2020
BVF Inc. IL acquired a new stake in Principia Biopharma Inc (NASDAQ:PRNB) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,716,734 shares of the com
Citigroup Inc. Has $763,000 Position in Principia Biopharma Inc (NASDAQ:PRNB)
10:18am, Friday, 20'th Mar 2020
Citigroup Inc. grew its stake in shares of Principia Biopharma Inc (NASDAQ:PRNB) by 1,117.4% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 13,927 shares o
SVB Leerink Brokers Lower Earnings Estimates for Principia Biopharma Inc (NASDAQ:PRNB)
05:38am, Monday, 16'th Mar 2020
Principia Biopharma Inc (NASDAQ:PRNB) – Research analysts at SVB Leerink reduced their FY2020 earnings per share (EPS) estimates for Principia Biopharma in a report issued on Wednesday, March 11th.
FY2023 EPS Estimates for Principia Biopharma Inc Reduced by SVB Leerink (NASDAQ:PRNB)
08:12am, Saturday, 14'th Mar 2020
Principia Biopharma Inc (NASDAQ:PRNB) – Equities research analysts at SVB Leerink cut their FY2023 earnings per share estimates for shares of Principia Biopharma in a research report issued to clien
Principia Biopharma (NASDAQ:PRNB) Rating Increased to Hold at Zacks Investment Research
08:58am, Friday, 13'th Mar 2020
Principia Biopharma (NASDAQ:PRNB) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “P
Charles Schwab Investment Management Inc. Purchases 47,333 Shares of Principia Biopharma Inc (NASDAQ:PRNB)
10:08am, Thursday, 12'th Mar 2020
Charles Schwab Investment Management Inc. lifted its position in Principia Biopharma Inc (NASDAQ:PRNB) by 69.9% during the 4th quarter, according to the company in its most recent filing with the SEC.
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma (PRNB), Constellation Pharmaceuticals
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma
BRIEF-Principia Biopharma Posts Quarterly Loss Per Share Of $0.80
08:14pm, Tuesday, 10'th Mar 2020
Principia Biopharma Inc:
